Area of research
Rheumatology · Hematology
Research interest
Research interests include Systemic Lupus Erythematosus Research, Autoimmune and Inflammatory Disorders Research, Rheumatoid Arthritis Research and Therapies, and SARS-CoV-2 and COVID-19 Research.
Effect of hydroxychloroquine dose reduction (2-3 mg/kg/day) on lipoprotein levels in stable lupus nephritis: A 12-month randomized controlled longitudinal study.
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 Study.
Autoantibody clusters in childhood-onset systemic lupus erythematosus: Insights from a multicenter study with 912 patients.
Metabolomics in juvenile idiopathic arthritis: A distinct profile in patients under methotrexate.
A real-life study of juvenile idiopathic arthritis from two Brazilian referral centers for pediatric rheumatology.
Quantitative PCR for parasitemia monitoring and preemptive therapy in patients with Chagas disease and autoimmune rheumatic disorders undergoing biologic treatment: a case series.
Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering.
Assessment of hydroxychloroquine blood levels in Sjögren's disease patients: drug adherence and clinical associations.
Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus.
Risk factors for mortality in 1528 Brazilian childhood-onset systemic lupus erythematosus patients.
Body Composition and Phase Angle: How to Improve Nutritional Evaluation in Juvenile Dermatomyositis Patients.
Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus.
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination.
Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases.
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial.
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus.
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis.
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine.
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis.
COVID-19 quarantine in adolescents with autoimmune rheumatic diseases: mental health issues and life conditions.
Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activity.
2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus.
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients.
Discontinuing methotrexate to enhance vaccine response.
Social impact of disease parameters and damage accrual in adult Brazilian patients with childhood-onset Systemic Lupus Erythematosus.
Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring.
Poor Prognosis of COVID-19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross-Sectional Population Study Of 252 119 Patients.